Literature DB >> 27815575

The Role of Interventional Oncology in the Management of Lung Cancer.

Ejona Duka1, Anna Maria Ierardi1, Chiara Floridi1, Alberto Terrana1, Federico Fontana1, Gianpaolo Carrafiello2.   

Abstract

Interventional radiological procedures for diagnosis and treatment of lung cancer have become increasingly important. Imaging-guided percutaneous biopsy has become the modality of choice for diagnosing lung cancer, and in the era of target therapies, it is an useful tool to define earlier patient-specific tumor phenotypes. In functionally inoperable patients, especially the ablative procedures are potentially curative alternatives to surgery. In addition to thermally ablative treatment, selective chemoembolization by a vascular access allows localized therapy. These treatments are considered for patients in a reduced general condition which does not allow systemic chemotherapy. The present article reviews the role of interventional oncology in the management of primary lung cancer, focusing on the state of the art for each procedure.

Entities:  

Keywords:  Interventional radiology; Lung cancer; Review

Mesh:

Year:  2016        PMID: 27815575     DOI: 10.1007/s00270-016-1495-y

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  6 in total

Review 1.  Immunotherapy and the Interventional Oncologist: Challenges and Opportunities-A Society of Interventional Oncology White Paper.

Authors:  Joseph P Erinjeri; Gabriel C Fine; Gosse J Adema; Muneeb Ahmed; Julius Chapiro; Martijn den Brok; Rafael Duran; Stephen J Hunt; D Thor Johnson; Jens Ricke; Daniel Y Sze; Beau Bosko Toskich; Bradford J Wood; David Woodrum; S Nahum Goldberg
Journal:  Radiology       Date:  2019-04-23       Impact factor: 11.105

2.  Radiofrequency versus microwave ablation for treatment of the lung tumours: LUMIRA (lung microwave radiofrequency) randomized trial.

Authors:  M Macchi; M P Belfiore; C Floridi; N Serra; G Belfiore; L Carmignani; R F Grasso; E Mazza; C Pusceddu; L Brunese; G Carrafiello
Journal:  Med Oncol       Date:  2017-04-18       Impact factor: 3.064

Review 3.  [Minimally Invasive Therapies for Early Stage Non-small Cell Lung Cancer].

Authors:  Tianyu He; Jinlin Cao; Jinming Xu; Wang Lv; Jian Hu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-02-28

4.  Diagnostic yield of CT-guided lung biopsies: how can we limit negative sampling?

Authors:  Marcello Andrea Tipaldi; Edoardo Ronconi; Miltiadis E Krokidis; Aleksejs Zolovkins; Gianluigi Orgera; Florindo Laurino; Julia Daffina; Damiano Caruso; Andrea Laghi; Michele Rossi
Journal:  Br J Radiol       Date:  2021-11-26       Impact factor: 3.039

5.  Drug-Eluting Bead Bronchial Arterial Chemoembolization With and Without Microwave Ablation for the Treatment of Advanced and Standard Treatment-Refractory/Ineligible Non-Small Cell Lung Cancer: A Comparative Study.

Authors:  Sheng Xu; Zhi-Xin Bie; Yuan-Ming Li; Bin Li; Fan-Lei Kong; Jin-Zhao Peng; Xiao-Guang Li
Journal:  Front Oncol       Date:  2022-03-15       Impact factor: 6.244

6.  Surgical resection, radiotherapy and percutaneous thermal ablation for treatment of stage 1 non-small cell lung cancer: protocol for a systematic review and network meta-analysis.

Authors:  Arun Chockalingam; Menelaos Konstantinidis; Brandon Koo; John Timothy Moon; Andrew Tran; Sahar Nourouzpour; Emily Lawson; Kathleen Fox; Peiman Habibollahi; Bruno Odisio; Mohammed Loya; Ali Bassir; Nariman Nezami
Journal:  BMJ Open       Date:  2022-06-16       Impact factor: 3.006

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.